Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1963
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 10
1964 9
1965 2
1966 4
1967 5
1968 10
1969 11
1970 8
1971 15
1972 13
1973 14
1974 15
1975 17
1976 11
1977 11
1978 8
1979 13
1980 14
1981 13
1982 12
1983 11
1984 17
1985 22
1986 12
1987 17
1988 23
1989 16
1990 13
1991 16
1992 33
1993 29
1994 25
1995 32
1996 19
1997 32
1998 39
1999 23
2000 42
2001 40
2002 35
2003 36
2004 50
2005 53
2006 51
2007 55
2008 58
2009 62
2010 64
2011 87
2012 73
2013 62
2014 76
2015 95
2016 78
2017 58
2018 70
2019 53
2020 64
2021 55
2022 62
2023 59
2024 40
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

1,915 results

Results by year

Filters applied: . Clear all
Page 1
Adrenocortical carcinoma.
Else T, Kim AC, Sabolch A, Raymond VM, Kandathil A, Caoili EM, Jolly S, Miller BS, Giordano TJ, Hammer GD. Else T, et al. Endocr Rev. 2014 Apr;35(2):282-326. doi: 10.1210/er.2013-1029. Epub 2013 Dec 20. Endocr Rev. 2014. PMID: 24423978 Free PMC article. Review.
Pediatric adrenocortical carcinoma.
Ilanchezhian M, Varghese DG, Glod JW, Reilly KM, Widemann BC, Pommier Y, Kaplan RN, Del Rivero J. Ilanchezhian M, et al. Front Endocrinol (Lausanne). 2022 Oct 31;13:961650. doi: 10.3389/fendo.2022.961650. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36387865 Free PMC article. Review.
Adrenocortical carcinoma (ACC) is a rare endocrine malignancy of the adrenal gland with an unfavorable prognosis. It is rare in the pediatric population, with an incidence of 0.2-0.3 patients per million in patients under 20 years old. It is primarily associated with Li-Fr …
Adrenocortical carcinoma (ACC) is a rare endocrine malignancy of the adrenal gland with an unfavorable prognosis. It is rare in the p …
Mild autonomous cortisol secretion: pathophysiology, comorbidities and management approaches.
Prete A, Bancos I. Prete A, et al. Nat Rev Endocrinol. 2024 Aug;20(8):460-473. doi: 10.1038/s41574-024-00984-y. Epub 2024 Apr 22. Nat Rev Endocrinol. 2024. PMID: 38649778 Review.
The majority of incidentally discovered adrenal tumours are benign adrenocortical adenomas and the prevalence of adrenocortical adenomas is around 1-7% on cross-sectional abdominal imaging. These can be non-functioning adrenal tumours or they can be associated with …
The majority of incidentally discovered adrenal tumours are benign adrenocortical adenomas and the prevalence of adrenocortical adeno …
New perspectives for mitotane treatment of adrenocortical carcinoma.
Puglisi S, Calabrese A, Basile V, Pia A, Reimondo G, Perotti P, Terzolo M. Puglisi S, et al. Best Pract Res Clin Endocrinol Metab. 2020 May;34(3):101415. doi: 10.1016/j.beem.2020.101415. Epub 2020 Mar 5. Best Pract Res Clin Endocrinol Metab. 2020. PMID: 32179008 Free article. Review.
The aim of adjuvant mitotane therapy is to reduce the risk of ACC recurrence following surgical removal of the tumor. Use of mitotane in an adjuvant setting is off-label, but the recent guidelines endorsed by the European Society of Endocrinology (ESE) and the European Net …
The aim of adjuvant mitotane therapy is to reduce the risk of ACC recurrence following surgical removal of the tumor. Use of mitotane …
Adrenocortical carcinoma: Diagnosis, prognostic classification and treatment of localized and advanced disease.
Libé R, Huillard O. Libé R, et al. Cancer Treat Res Commun. 2023;37:100759. doi: 10.1016/j.ctarc.2023.100759. Epub 2023 Sep 8. Cancer Treat Res Commun. 2023. PMID: 37690343 Free article. Review.
It is an aggressive cancer originating in the cortex of the adrenal gland with a poor prognosis. The 5-year survival rate is less than 15% among patients with metastatic disease. ...
It is an aggressive cancer originating in the cortex of the adrenal gland with a poor prognosis. The 5-year survival rate is l …
Adrenocortical carcinoma.
Baudin E; Endocrine Tumor Board of Gustave Roussy. Baudin E, et al. Endocrinol Metab Clin North Am. 2015 Jun;44(2):411-34. doi: 10.1016/j.ecl.2015.03.001. Endocrinol Metab Clin North Am. 2015. PMID: 26038209 Review.
American Association of Clinical Endocrinology Disease State Clinical Review on the Evaluation and Management of Adrenocortical Carcinoma in an Adult: a Practical Approach.
Kiseljak-Vassiliades K, Bancos I, Hamrahian A, Habra M, Vaidya A, Levine AC, Else T. Kiseljak-Vassiliades K, et al. Endocr Pract. 2020 Nov;26(11):1366-1383. doi: 10.4158/DSCR-2020-0567. Epub 2020 Dec 14. Endocr Pract. 2020. PMID: 33875173 Free PMC article. Review.
RESULTS: Adrenocortical carcinoma is a rare malignancy, often with poor outcomes. For any patient with an adrenal mass suspicious for adrenocortical carcinoma, the approach should include prompt evaluation with detailed history and physical exam, imaging, and biochemical …
RESULTS: Adrenocortical carcinoma is a rare malignancy, often with poor outcomes. For any patient with an adrenal mass suspicious for …
Pediatric adrenocortical tumours.
Pinto EM, Zambetti GP, Rodriguez-Galindo C. Pinto EM, et al. Best Pract Res Clin Endocrinol Metab. 2020 May;34(3):101448. doi: 10.1016/j.beem.2020.101448. Epub 2020 Jul 3. Best Pract Res Clin Endocrinol Metab. 2020. PMID: 32636100 Review.
Less than 10% of patients with ACT exhibit no endocrine syndrome at presentation, although some show abnormal concentrations of adrenal cortex hormones. Pediatric ACT is commonly associated with constitutional genetic and/or epigenetic alterations, represented by ge …
Less than 10% of patients with ACT exhibit no endocrine syndrome at presentation, although some show abnormal concentrations of adrenal
Adrenal incidentalomas.
Bertherat J, Mosnier-Pudar H, Bertagna X. Bertherat J, et al. Curr Opin Oncol. 2002 Jan;14(1):58-63. doi: 10.1097/00001622-200201000-00011. Curr Opin Oncol. 2002. PMID: 11790982 Review.
The term adrenal incidentaloma refers to an adrenal mass occasionally and unexpectedly discovered by an abdominal imaging procedure performed for reasons a priori unrelated to adrenal dysfunction. ...The pathogenesis of adrenal tumors is not well under …
The term adrenal incidentaloma refers to an adrenal mass occasionally and unexpectedly discovered by an abdominal imaging proc …
1,915 results